Seres Therapeutics (MCRB)
NASDAQ:MCRB
Holding MCRB?
Track your performance easily

Seres Therapeutics (MCRB) Financial Statements

1,010 Followers

Seres Therapeutics Financial Overview

Seres Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.183; its P/E ratio is -0.69; Seres Therapeutics is scheduled to report earnings on November 6, 2024, and the estimated EPS forecast is $-0.08. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue--$ 64.00K$ 310.00K$ 126.47M
Gross Profit--$ 64.00K$ 310.00K$ 126.47M
EBIT$ -29.42M$ -33.05M-$ -44.88M$ 53.95M
EBITDA$ -27.52M$ -31.03M-$ -42.80M$ 55.58M
Net Income Common Stockholders$ -35.46M$ -37.72M$ -41.25M$ -48.89M$ 46.55M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 71.23M$ 111.18M$ 127.97M$ 169.91M$ 229.52M
Total Assets$ 321.73M$ 341.26M$ 358.60M$ 367.70M$ 406.39M
Total Debt$ 212.63M$ 214.18M$ 213.94M$ 212.28M$ 212.92M
Net Debt$ 141.39M$ 103.00M$ 85.97M$ 42.37M$ -16.60M
Total Liabilities$ 408.81M$ 401.00M$ 403.46M$ 382.82M$ 383.77M
Stockholders Equity$ -87.07M$ -59.74M$ -44.86M$ -15.12M$ 22.61M
Cash Flow-
Free Cash Flow$ -39.91M$ -35.30M-$ -61.05M$ 64.75M
Operating Cash Flow$ -39.81M$ -35.24M$ -47.50M$ -59.26M$ 65.98M
Investing Cash Flow$ 1.30M$ -62.00K$ -877.00K$ -1.80M$ 10.52M
Financing Cash Flow-$ 18.76M$ 6.43M$ 1.44M$ 58.18M
Currency in USD

Seres Therapeutics Earnings and Revenue History

Seres Therapeutics Debt to Assets

Seres Therapeutics Cash Flow

Seres Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis